- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/72 - QuinazolinesQuinazolines hydrogénées
Détention brevets de la classe C07D 239/72
Brevets de cette classe: 263
Historique des publications depuis 10 ans
|
17
|
7
|
9
|
10
|
12
|
14
|
16
|
15
|
11
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4486 |
8 |
| Merck Patent GmbH | 5735 |
8 |
| Janssen Pharmaceutica N.V. | 3160 |
5 |
| Gilead Sciences, Inc. | 2236 |
5 |
| Merck Sharp & Dohme Corp. | 2183 |
4 |
| Nerviano Medical Sciences S.r.l. | 237 |
4 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3328 |
4 |
| Merck Sharp & Dohme LLC | 3737 |
4 |
| Emory University | 1723 |
3 |
| Exelixis, Inc. | 394 |
3 |
| Hutchison MediPharma Enterprises Limited | 10 |
3 |
| Myriad Pharmaceuticals, Inc. | 10 |
3 |
| Reata Pharmaceuticals, Inc. | 115 |
3 |
| Sichuan Huiyu Pharmaceutical Co., Ltd. | 37 |
3 |
| Wuhan LL Science and Technology Development Co., Ltd | 72 |
3 |
| Hutchmed Limited | 47 |
3 |
| Sichuan Huiyu Seacross Pharmaceutical Technology Co., Ltd. | 28 |
3 |
| Bristol-myers Squibb Company | 4757 |
2 |
| Genentech, Inc. | 4114 |
2 |
| President and Fellows of Harvard College | 6105 |
2 |
| Autres propriétaires | 188 |